Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 10,904
Change Today +374.00 / 3.55%
Volume 4.5M
MDC On Other Exchanges
Symbol
Exchange
Johannesburg
Berlin
As of 11:00 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

mediclinic international ltd (MDC) Snapshot

Open
$10,530
Previous Close
$10,530
Day High
$10,925
Day Low
$10,500
52 Week High
04/23/15 - $13,459
52 Week Low
06/25/14 - $7,857
Market Cap
94.6B
Average Volume 10 Days
2.8M
EPS TTM
$4.84
Shares Outstanding
868.0M
EX-Date
06/12/15
P/E TM
22.5x
Dividend
$106.50
Dividend Yield
0.91%
Current Stock Chart for MEDICLINIC INTERNATIONAL LTD (MDC)

Related News

No related news articles were found.

mediclinic international ltd (MDC) Related Businessweek News

No Related Businessweek News Found

mediclinic international ltd (MDC) Details

Mediclinic International Limited, together with its subsidiaries, operates private hospitals in South Africa, Namibia, Switzerland, and the United Arab Emirates. The company offers acute care multidisciplinary hospital and related services under the Mediclinic and Hirslanden brand names. It operates 49 private hospitals in South Africa and 3 in Namibia with 7,614 beds; 14 private hospitals with 1,567 beds in Switzerland; and 2 hospitals with 382 beds and 8 clinics in Dubai in the United Arab Emirates. The company was formerly known as Medi-Clinic Corporation Limited and changed its name to Mediclinic International Limited in September 2011. Mediclinic International Limited was founded in 1983 and is headquartered in Stellenbosch, South Africa.

27,516 Employees
Last Reported Date: 05/21/15
Founded in 1983

mediclinic international ltd (MDC) Top Compensated Officers

Chief Executive Officer, Executive Director, ...
Total Annual Compensation: R9.0M
Chief Financial Officer and Executive Directo...
Total Annual Compensation: R7.0M
Executive Director, Member of Investment Sub-...
Total Annual Compensation: R10.9M
Chief Executive Officer of Mediclinic Middle ...
Total Annual Compensation: R6.3M
Executive Director, Member of Investment Sub-...
Total Annual Compensation: R5.5M
Compensation as of Fiscal Year 2014.

mediclinic international ltd (MDC) Key Developments

Mediclinic International Limited Declares Dividend, Payable on June 22, 2015

Mediclinic International Limited announced that the directors have declared a final gross cash dividend in respect of the year under review of 75.5 cents (2014: 68.0 cents) (64.1750 cents (2014: 57.8000 cents) net of dividend withholding tax) per ordinary share. The dividend declared increased by 11% compared to the comparative period. Together with the interim dividend declared during November 2014, the total gross dividend relating to the year under review increased by 11% to 106.5 cents (2014: 96.0 cents). The dividend is payable on June 22, 2015, record date is June 19, 2015.

Mediclinic International Limited Reports Audited Consolidated Earnings Results for the Full Year Ended March 31, 2015

Mediclinic International Limited reported audited consolidated earnings results for the full year ended March 31, 2015. For the year, the company reported revenues were ZAR 35,238 million against ZAR 30,495 million a year ago. Operating profit was ZAR 5,723 million against ZAR 5,505 million a year ago. Profit before tax was ZAR 4,741 million against ZAR 4,362 million a year ago. Profit attributable to equity holders of the company was ZAR 4,297 million or 500.0 cents diluted per share against ZAR 3,385 million or 408.0 cents diluted per share a year ago. Headline earnings was ZAR 4,081 million or 474.9 cents diluted per share against ZAR 3,355 million or 404.4 cents diluted per share a year ago. Cash flow from operating activities was ZAR 6,008 million against ZAR 4,615 million a year ago. Investment to expand operations was ZAR 2,214 million against ZAR 1,679 million a year ago. Group normalised revenue increased by 16% for the period under review. Normalised operating profit before interest, tax, depreciation and amortisation (normalised EBITDA) was 11% higher at ZAR 7,179 million against ZAR 6,467 million and basic normalised headline earnings per share was 9% higher at 408.2 cents against 375.8 cents in 2014.

Mediclinic International Limited Provides Earnings Guidance for the Full Year Ended March 31, 2015

Mediclinic International Limited provided earnings guidance for the full year ended March 31, 2015. The company's basic earnings per share for the year ended March 31, 2015 are expected to be between 83.4 cents and 104.2 cents, or 20% and 25% higher than the restated 416.8 cents reported for the year ended March 31, 2014. The company's basic EPS, basic headline earnings per share (HEPS) and normalised HEPS for the previous period were adjusted in terms of IAS 33 paragraph 26 and released on SENS on November 6, 2014. In order to provide clear and meaningful guidance to shareholders, this trading statement will also address basic HEPS and normalized HEPS. Normalised HEPS are defined as reportable HEPS in terms of accounting standards, excluding one-off and exceptional items. The company's basic HEPS for the year ended March 31, 2015 are expected to be between 62.0 cents and 82.6 cents, or 15% and 20% higher than the 413.1 cents reported for the previous period. Excluding the one-off and exceptional items, basic normalised HEPS are expected to be between 30.1 cents and 37.6 cents, or 8% and 10% higher than the 375.8 cents reported for the previous period.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDC:SJ 10,904.00 +374.00

MDC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDC.
View Industry Companies
 

Industry Analysis

MDC

Industry Average

Valuation MDC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICLINIC INTERNATIONAL LTD, please visit www.mediclinic.co.za. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.